Saliva samples for COVID-19 testing: as good as nasopharyngeal swabs, but cheaper
New meta-analysis of 37 studies and over 7,000 paired saliva and nasopharyngeal swab samples
Could a different testing strategy reduce healthcare workers’ isolation after unprotected exposure to a confirmed case of COVID-19?
RI-MUHC study suggests appropriate...
Getting Canadians moving, with the help of AI!
App developed by Dr. Abhinav Sharma selected for Healthy Futures Accelerator
Franco Carnevale awarded nursing Badge of Merit
Outstanding nurse, researcher and pediatric clinical ethicist recognized by the Ordre des infirmières et infirmiers du Québec
RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians
Canada approves HIV self-testing kit ahead of World AIDS Day 2020
What do we know about sleep apnea, pregnancy and gestational diabetes?
RI-MUHC researchers find link that may lead to better health for mother and baby
Dr. Natalie Dayan receives New Investigator Award from the Canadian Society of Internal Medicine
Honouring research that takes women’s heart health to heart!
Two members of the RI-MUHC elected fellows of the Canadian Academy of Health Sciences
Congratulations to Marina Klein and Bernard Robaire!
The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
RI-MUHC researcher Christina Wolfson co-leads study investing in our most...
Spike in peanut and nut anaphylaxis in children at Halloween and Easter
New study suggests education and awareness are needed to help reduce risk of anaphylaxis at specific times of the year
$2M funding to mitigate COVID-19 impact on tuberculosis services
Dr. Madhukar Pai launches studies in India, Indonesia, Nigeria and Peru
Sleep apnea treatment reduces heart problems in patients with prediabetes, a new study finds
People with prediabetes and obstructive sleep apnea could reduce their daytime resting heart rate and risk of cardiovascular disease by using a CPAP machine at night
New study of therapy options in metastatic melanoma
RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors
Nip it in the bud: New study will attack SARS-Cov2 where it multiplies
RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening
Serious Flaws in Studies Linking COVID-19 and Air Pollution
Studies have yet to prove this link, say Carleton and McGill University epidemiologists
Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach
In a new cost-analysis study, researchers recommend widespread testing of...
Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19
Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations
COVID-19 Q&A on dealing with pandemic fatigue
“We need to strike a balance and take our anxiety down from an unhealthy to a manageable level,” says researcher Jason Harley
New study shows that persistence of ADHD into adulthood is an important predictor of car crash risk
RI-MUHC researcher Dr. Lily Hechtman is senior author of a 20-year study
Lashanda Skerritt awarded Vanier Canada Graduate Scholarship
“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...